The association of vitamin D binding protein levels and genotypes with type 1 diabetes in the black South African population

Autor: Eleanor M Cave, Sureka Bhola, Nigel J Crowther, Carolyn J Padoa

Publikováno v: BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-8 (2022)

Abstract Background Vitamin D deficiency and the vitamin D pathway have previously been associated with type 1 diabetes (T1D). The majority of vitamin D is transported through the blood bound to the vitamin D binding protein (VDBP). Two polymorphisms

Externí odkaz: https://doaj.org/article/125692aebbbd402a8bdd477a77f93023

Evaluation of the impact of delayed centrifugation on the diagnostic performance of serum creatinine as a baseline measure of renal function before antiretroviral treatment

Autor: Chemedzai E. Chikomba, Carolyn J. Padoa, Donald Tanyanyiwa

Publikováno v: Southern African Journal of HIV Medicine, Vol 21, Iss 1, Pp e1-e15 (2020)

Background: The measurement of serum creatinine is a standard requirement of the medical management of people living with HIV. Renal dysfunction is common, both as a complication of HIV-infection and as a result of its treatment. The detection of abn

Externí odkaz: https://doaj.org/article/82dd87db9e964421b5c17e8103d1b1e7

The association of vitamin D binding protein levels and genotypes with type 1 diabetes in the black South African population

Autor: Eleanor M Cave, Sureka Bhola, Nigel J Crowther, Carolyn J Padoa

Publikováno v: BMC endocrine disorders. 22(1)

Background Vitamin D deficiency and the vitamin D pathway have previously been associated with type 1 diabetes (T1D). The majority of vitamin D is transported through the blood bound to the vitamin D binding protein (VDBP). Two polymorphisms in the V

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea081c75a78934af8eb956bf66a3e51
https://pubmed.ncbi.nlm.nih.gov/35843941

Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies

Autor: J. Paul Banga, Laszlo Hegedüs, Jacqueline A. Gilbert, Daniel El Fassi, Carolyn J. Padoa, Claus Henrik Nielsen

Publikováno v: El Fassi, D, Banga, J P, Gilbert, J A, Padoa, C, Hegedüs, L & Nielsen, C H 2008, ' Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies ', Clinical Immunology, vol. 130, no. 3, pp. 252-258 . https://doi.org/10.1016/j.clim.2008.09.007

Udgivelsesdato: 2008-Oct-27 Treatment of Graves' disease (GD) with the B-lymphocyte depleting agent rituximab in addition to standard methimazole-therapy prolongs remission. Paradoxically, it does not mediate a reduction in thyrotropin receptor antib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e14070a32924303d5cae33d6404cfc
https://doi.org/10.1016/j.clim.2008.09.007

Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes

Autor: E Ortqvist, Mona Landin-Olsson, Carolyn J. Padoa, James W. Thomas, Carina Törn, T. R. Hall, Christiane S. Hampe

Publikováno v: Clinical and Experimental Immunology. 146:9-14

Summary Autoantibodies to insulin (IAA) are one of the first markers of the autoimmune process leading to type 1 diabetes (T1D). While other autoantibodies in T1D have been studied extensively, relatively little is known about IAA and their binding s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da644f98fa0372f95d7fe81519ea2e6c
https://doi.org/10.1111/j.1365-2249.2006.03178.x